We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Arcturus Therapeutics Holdings Inc
28 own
18 watching
Current Price
$16.76
$0.16
(0.99%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
557.34M
52-Week High
45
52-Week Low
14.30000
Average Volume
0.48M
Dividend Yield
--
P/E Ratio
--
Market Capitalization557.34M52-Week High4552-Week Low14.30000Average Volume0.48MDividend Yield--P/E Ratio--What does the Arcturus Therapeutics Holdings Inc do?
Arcturus Therapeutics is developing a portfolio of mRNA therapeutics for treatment of diseases with unmet medical needs. Our hope and vision are to build transformative, life-changing medicines for patients and their families.
Our team has extensive experience in the discovery and development of mRNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely position us to catalyze the next generation of mRNA medicines.
Read More
How much money does Arcturus Therapeutics Holdings Inc make?
News & Events about Arcturus Therapeutics Holdings Inc.
Ticker Report
1 year ago
Sumitomo Mitsui Trust Holdings Inc. reduced its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT Get Rating) by 0.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,449,060 shares of ...
Market News Video
1 year ago
In trading on Tuesday, shares of Arcturus Therapeutics Holdings Inc (ARCT) crossed below their 200 day moving average of 17.41, changing hands as low as 17.40 per share. Arcturus Therapeutics Holdings Inc shares are currently trading off about 3.5% on the day...
Business Wire
1 year ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Arcturus Therapeutics, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today...
Business Wire
2years ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the...
Business Wire
2years ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that is has...
Frequently Asked Questions
Frequently Asked Questions
What is Arcturus Therapeutics Holdings Inc share price today?
Can Indians buy Arcturus Therapeutics Holdings Inc shares?
How can I buy Arcturus Therapeutics Holdings Inc shares from India?
Can Fractional shares of Arcturus Therapeutics Holdings Inc be purchased?
What are the documents required to start investing in Arcturus Therapeutics Holdings Inc stocks?
What is today’s traded volume of Arcturus Therapeutics Holdings Inc?
What is today’s market capitalisation of Arcturus Therapeutics Holdings Inc?
What is the 52-Week High and Low Range of Arcturus Therapeutics Holdings Inc?
What percentage is Arcturus Therapeutics Holdings Inc down from its 52-Week High?
What percentage is Arcturus Therapeutics Holdings Inc up from its 52-Week Low?
Current Price
$16.76
$0.16
(0.99%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.